4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0000905148-25-003320
Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gagnon Robert E. Chief Financial Officer | 2025-09-10 | Grant or award | +200,000 | 200,000 | D | ||
| Derivatives | |||||||
| Gagnon Robert E. Chief Financial Officer | 2025-09-02 | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | D | ||
Loading xslF345X05/form4.xml…